SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gland Pharma informs about allotment of equity shares under ESOP

05 Jul 2021 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has informed that the ESOP Compensation Committee of the Board of Directors of the Company has allotted 332,450 Equity shares of Rs 1 each of the Company, fully paid up, on July 5, 2021 to employees on exercise of their Stock Options pursuant to Gland Pharma Employee Stock Options Scheme, 2019. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs 164,237,173 comprising of 164,237,173 Equity shares of face value Rs1 each.

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1795.80 59.80 (3.44%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×